Yatırımcı.AI

MEDTR vs TUPRS Comparison

Price, market cap, valuation, profitability and leverage metrics of MEDTR and TUPRS side by side.

MEDTRTUPRS
StockFund

If You Had Invested TRY 10,000

Metric Comparison

MEDTR vs TUPRS Comparison
MetricMEDTRTUPRSSector median
Last price (TL)17.46322.7512.18
Daily change−2.40%−3.58%−2.84%
Market capTRY 2.1BTRY 621.9BTRY 3.7B
P/E170.174.7915.84
P/B0.591.190.86
Dividend yield0.66%1.78%0.91%
Return on equity0.34%26.59%0.48%
Free float20.21%49.03%35.05%
Ratios are calculated from the latest published financial statements.

Popular Comparisons

Related Pages

About the MEDTR vs TUPRS Comparison

Price, market cap, valuation multiples, profitability and leverage of MEDTR (Meditera Tibbi Malzeme) and TUPRS (Tüpraş) side by side as of Nov 20, 2026, 18:19. Of the 15 metrics compared, MEDTR leads in 6 and TUPRS leads in 9.

Highlights: Daily change: MEDTR leads (−2.40% vs −3.58%). Market cap: TUPRS leads (TRY 621.9B vs TRY 2.1B). P/E: TUPRS leads (4.79 vs 170.17). P/B: MEDTR leads (0.59 vs 1.19). EV/EBITDA: TUPRS leads (2.51 vs 4.77). EV/Sales: TUPRS leads (0.36 vs 0.70). Dividend yield: TUPRS leads (1.78% vs 0.66%). Gross margin: MEDTR leads (35.58% vs 15.56%).

Frequently Asked Questions

By P/E, TUPRS is cheaper (170.17 vs 4.79); by P/B, MEDTR trades at the lower multiple (0.59 vs 1.19).

Annual net margin is 0.49% for MEDTR and 10.56% for TUPRS; return on equity is 0.34% for MEDTR and 26.59% for TUPRS.

The leverage ratio is 16.46 for MEDTR and 45.39 for TUPRS; net debt/EBITDA is — for MEDTR and −1.22 for TUPRS. Lower values mean less leverage.

Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.